[Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
作者信息
Berent H, Kancelarczyk W L, Zebrowski M, Uchman B
出版信息
Pol Tyg Lek. 1988 Jun 13;43(24):776-8.
PMID:3237518
Abstract
摘要
相似文献
1
2
[Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Pol Tyg Lek. 1988 Aug 22;43(34):1092-4.
3
Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1987;114(4):549-54.
4
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Z Gesamte Inn Med. 1989 Feb 1;44(3):77-9.
5
[Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
Med Monatsschr. 1976 Jul;30(7):323-6.
6
[Treatment of vascular diseases of the extremities using pentoxifylline].
Ric Clin Lab. 1988;18 Suppl 2:49-56.
7
[Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Ric Clin Lab. 1981;11 Suppl 1:303-11.
8
Fibrinolytic activity and the effects of beta-pyridylcarbinol (Ronicol) in patients with arteriosclerosis obliterans.
Thromb Haemost. 1983 Dec 30;50(4):797-9.
9
10
[The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
Z Gesamte Inn Med. 1991 Apr;46(6):185-90.
Zotero 插件